Last reviewed · How we verify

NCT03925311

Transcriptome Profiling and Endometrial Receptivity

Recruiting now Last updated 27 March 2025
What this trial tests

trial testing endometrial biopsy and blood sampling in Pregnancy Related in 220 participants. Currently enrolling.

Timeline
20 April 2015
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorChinese University of Hong Kong
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment220
Start date20 April 2015
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 20 to 40, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to correlate and identify the biochemical markers which may reflect WOI. Blood samples will be collected and endometrial biopsy will be performed at particular time points.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03925311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing